Programs for Assessment of Technology in Health
Loss of health related quality of life following low-trauma fractures in the elderly.
The current economic burden of illness of osteoporosis in Canada.
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Management of hospital formularies in Ontario: challenges with a Local Health Integration Network.
Economic burden of illness associated with diabetic foot ulcers in Canada.
Comparative value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing in combination versus individually for the diagnosis of undifferentiated patients with suspected inflammatory disease or serious infection: a systematic review and economic analysis.
Time and labor costs associated with administration of intravenous bisphosphonates for breast or prostate cancer patients with metastatic bone disease: a time and motion study.
Harmonization of health technology assessment and regulatory approval processes: a systematic review of international experiences.
Human fibrinogen concentreate (RiaSTAP): comparative cost-effectiveness evaluation.
The burden of atrial fibrillation on the hospital sector in Canada.
Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis.
Economic appraisal of a community-wide cardiovascular health awareness program.
Cost-effectivenessof the carbon-13 urea breath test for the detection of helicobacter pylori: an economic analysis.
Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
Photoselective vaporization for the treatment of benign prostatic hyperplasia.
Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework.
Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update.
Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B).
High-sensitivity cardiac troponin for the rapid diagnosis of acute coronary syndrome in the emergency department: a clinical and cost-effectiveness evaluation [science report].
Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi study.
Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents.
The burden of illness of osteoporosis in Canada.
The burden of illness of osteoporosis in Canadian men.
Epilepsy care in Ontario: an economic analysis of increasing access to epilepsy surgery.
Newborn screening for Krabbe Leukodystrophy: a review of the clinical and cost effectiveness and guidelines.
Cost-effectiveness of interventions for chronic obstructive pulmonary disease using an Ontario policy model.
Treatment for depresson after unsatisfactory response to SSRIs [Internet].